US Physical Therapy (USPH) Stock Price
US Physical Therapy Price
Revenue has compounded at 9.7% per year over the past 19 years to 780.99 M USD. Earnings per share have grown at 3.2% per year over the last 19 years. US Physical Therapy's net margin stands at 1.9%, down from 5.6% several years earlier. US Physical Therapy currently offers a dividend yield of about 2.35%. The payout ratio is around 181% of earnings. The dividend has grown at 13.1% per year over the past 14 years. Analysts set a median price target of 103.53 USD, implying 35.4% above the current price. Of 13 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 30% above its 52-week low.
US Physical Therapy stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of US Physical Therapy over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how US Physical Therapy stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing US Physical Therapy's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | US Physical Therapy Price |
|---|---|
| 8/6/2026 | 76.46 USD |
| 8/5/2026 | 77.46 USD |
| 8/4/2026 | 77.72 USD |
| 8/3/2026 | 77.81 USD |
| 7/31/2026 | 79.06 USD |
| 7/30/2026 | 80.13 USD |
| 7/29/2026 | 80.26 USD |
| 7/27/2026 | 75.83 USD |
| 7/23/2026 | 72.97 USD |
| 7/22/2026 | 74.38 USD |
| 7/21/2026 | 74.74 USD |
| 7/20/2026 | 74.42 USD |
| 7/17/2026 | 73.56 USD |
| 7/16/2026 | 74.19 USD |
| 7/15/2026 | 71.38 USD |
| 7/14/2026 | 70.00 USD |
| 7/13/2026 | 72.17 USD |
| 7/10/2026 | 72.54 USD |
| 7/9/2026 | 73.45 USD |
| 7/8/2026 | 70.58 USD |
| 7/7/2026 | 71.80 USD |
| 7/6/2026 | 71.66 USD |
| 7/2/2026 | 72.35 USD |
| 7/1/2026 | 71.31 USD |
| 6/30/2026 | 68.68 USD |
| 6/29/2026 | 67.63 USD |
| 6/26/2026 | 68.78 USD |
| 6/25/2026 | 66.32 USD |
| 6/24/2026 | 66.21 USD |
| 6/23/2026 | 63.50 USD |
| 6/22/2026 | 61.73 USD |
| 6/18/2026 | 62.96 USD |
| 6/17/2026 | 65.67 USD |
| 6/16/2026 | 65.54 USD |
| 6/15/2026 | 66.01 USD |
| 6/12/2026 | 66.38 USD |
| 6/11/2026 | 64.14 USD |
| 6/10/2026 | 62.10 USD |
| 6/9/2026 | 61.80 USD |
| 6/8/2026 | 61.30 USD |
| 6/5/2026 | 63.17 USD |
| 6/4/2026 | 62.70 USD |
| 6/3/2026 | 61.67 USD |
| 6/2/2026 | 62.04 USD |
| 6/1/2026 | 63.47 USD |
| 5/29/2026 | 64.57 USD |
| 5/28/2026 | 63.81 USD |
| 5/27/2026 | 63.49 USD |
| 5/26/2026 | 61.82 USD |
| 5/22/2026 | 61.72 USD |
| 5/21/2026 | 62.69 USD |
| 5/20/2026 | 61.99 USD |
| 5/19/2026 | 61.61 USD |
| 5/18/2026 | 65.04 USD |
| 5/15/2026 | 62.81 USD |
| 5/14/2026 | 65.09 USD |
| 5/13/2026 | 60.14 USD |
| 5/12/2026 | 60.85 USD |
| 5/11/2026 | 59.42 USD |
| 5/8/2026 | 59.29 USD |
| 5/7/2026 | 59.00 USD |
| 5/6/2026 | 73.65 USD |
| 5/5/2026 | 71.74 USD |
| 5/4/2026 | 70.92 USD |
| 5/1/2026 | 71.83 USD |
| 4/30/2026 | 71.22 USD |
| 4/29/2026 | 71.51 USD |
| 4/28/2026 | 72.54 USD |
| 4/27/2026 | 73.19 USD |
| 4/24/2026 | 73.53 USD |
| 4/23/2026 | 74.76 USD |
| 4/22/2026 | 75.52 USD |
| 4/21/2026 | 75.53 USD |
| 4/20/2026 | 75.72 USD |
| 4/17/2026 | 76.57 USD |
| 4/16/2026 | 78.18 USD |
| 4/15/2026 | 76.67 USD |
| 4/14/2026 | 77.13 USD |
| 4/13/2026 | 78.34 USD |
| 4/10/2026 | 76.48 USD |
| 4/9/2026 | 77.01 USD |
| 4/8/2026 | 76.74 USD |
| 4/7/2026 | 74.86 USD |
| 4/6/2026 | 74.04 USD |
| 4/2/2026 | 73.74 USD |
| 4/1/2026 | 74.40 USD |
| 3/31/2026 | 74.96 USD |
| 3/30/2026 | 74.79 USD |
| 3/27/2026 | 74.75 USD |
| 3/26/2026 | 74.42 USD |
| 3/25/2026 | 74.96 USD |
| 3/24/2026 | 74.89 USD |
| 3/23/2026 | 75.20 USD |
| 3/20/2026 | 73.86 USD |
| 3/19/2026 | 74.33 USD |
| 3/18/2026 | 74.33 USD |
| 3/17/2026 | 77.41 USD |
| 3/16/2026 | 77.98 USD |
| 3/13/2026 | 76.83 USD |
| 3/12/2026 | 77.88 USD |
| 3/11/2026 | 79.84 USD |
| 3/10/2026 | 79.99 USD |
| 3/9/2026 | 80.57 USD |
| 3/6/2026 | 81.09 USD |
| 3/5/2026 | 82.63 USD |
| 3/4/2026 | 84.09 USD |
| 3/3/2026 | 83.25 USD |
| 3/2/2026 | 83.03 USD |
| 2/27/2026 | 82.96 USD |
| 2/26/2026 | 79.34 USD |
| 2/25/2026 | 81.68 USD |
| 2/24/2026 | 82.88 USD |
| 2/23/2026 | 83.55 USD |
| 2/20/2026 | 85.09 USD |
| 2/19/2026 | 86.45 USD |
| 2/18/2026 | 86.44 USD |
| 2/17/2026 | 86.54 USD |
| 2/13/2026 | 86.94 USD |
| 2/12/2026 | 87.54 USD |
| 2/11/2026 | 88.14 USD |
| 2/10/2026 | 85.41 USD |
| 2/9/2026 | 84.48 USD |
| 2/6/2026 | 85.58 USD |
| 2/5/2026 | 84.07 USD |
| 2/4/2026 | 82.60 USD |
| 2/3/2026 | 82.12 USD |
| 2/2/2026 | 83.66 USD |
| 1/30/2026 | 83.87 USD |
| 1/29/2026 | 82.36 USD |
| 1/28/2026 | 82.51 USD |
| 1/27/2026 | 83.03 USD |
| 1/26/2026 | 85.78 USD |
| 1/23/2026 | 85.70 USD |
| 1/22/2026 | 87.47 USD |
| 1/21/2026 | 86.01 USD |
| 1/20/2026 | 85.11 USD |
| 1/16/2026 | 86.00 USD |
| 1/15/2026 | 87.70 USD |
| 1/14/2026 | 85.92 USD |
| 1/13/2026 | 85.72 USD |
| 1/12/2026 | 84.29 USD |
| 1/9/2026 | 83.96 USD |
| 1/8/2026 | 81.48 USD |
| 1/7/2026 | 79.47 USD |
| 1/6/2026 | 81.25 USD |
| 1/5/2026 | 84.24 USD |
| 1/2/2026 | 78.88 USD |
| 12/31/2025 | 78.09 USD |
| 12/30/2025 | 81.27 USD |
| 12/29/2025 | 81.42 USD |
| 12/26/2025 | 81.00 USD |
| 12/24/2025 | 80.24 USD |
| 12/23/2025 | 80.00 USD |
| 12/22/2025 | 80.45 USD |
| 12/19/2025 | 77.86 USD |
| 12/18/2025 | 78.72 USD |
| 12/17/2025 | 78.72 USD |
| 12/16/2025 | 78.50 USD |
| 12/15/2025 | 81.15 USD |
| 12/12/2025 | 80.59 USD |
| 12/11/2025 | 80.42 USD |
| 12/10/2025 | 79.28 USD |
| 12/9/2025 | 76.26 USD |
| 12/8/2025 | 75.34 USD |
| 12/5/2025 | 75.03 USD |
| 12/4/2025 | 76.30 USD |
| 12/3/2025 | 75.41 USD |
| 12/2/2025 | 73.47 USD |
| 12/1/2025 | 73.52 USD |
| 11/28/2025 | 73.85 USD |
| 11/26/2025 | 73.94 USD |
| 11/25/2025 | 74.16 USD |
| 11/24/2025 | 71.50 USD |
| 11/21/2025 | 71.63 USD |
| 11/20/2025 | 68.41 USD |
| 11/19/2025 | 67.98 USD |
| 11/18/2025 | 68.94 USD |
| 11/17/2025 | 70.01 USD |
| 11/14/2025 | 71.67 USD |
| 11/13/2025 | 71.22 USD |
| 11/12/2025 | 72.53 USD |
| 11/11/2025 | 74.39 USD |
| 11/10/2025 | 73.30 USD |
| 11/7/2025 | 73.87 USD |
| 11/6/2025 | 77.56 USD |
| 11/5/2025 | 88.05 USD |
| 11/4/2025 | 87.04 USD |
| 11/3/2025 | 86.93 USD |
| 10/31/2025 | 86.27 USD |
| 10/30/2025 | 86.22 USD |
| 10/29/2025 | 88.08 USD |
| 10/28/2025 | 89.94 USD |
| 10/27/2025 | 91.00 USD |
| 10/24/2025 | 93.16 USD |
| 10/23/2025 | 91.34 USD |
| 10/22/2025 | 90.20 USD |
| 10/21/2025 | 89.62 USD |
| 10/20/2025 | 89.62 USD |
| 10/17/2025 | 88.93 USD |
| 10/16/2025 | 89.50 USD |
| 10/15/2025 | 91.68 USD |
| 10/14/2025 | 90.97 USD |
| 10/13/2025 | 88.68 USD |
| 10/10/2025 | 87.72 USD |
| 10/9/2025 | 88.86 USD |
| 10/8/2025 | 90.38 USD |
| 10/7/2025 | 89.77 USD |
| 10/6/2025 | 89.53 USD |
| 10/3/2025 | 89.28 USD |
| 10/2/2025 | 87.20 USD |
| 10/1/2025 | 86.00 USD |
| 9/30/2025 | 84.95 USD |
| 9/29/2025 | 83.50 USD |
| 9/28/2025 | 83.50 USD |
| 9/25/2025 | 83.40 USD |
| 9/24/2025 | 82.52 USD |
| 9/23/2025 | 79.12 USD |
| 9/22/2025 | 79.87 USD |
| 9/19/2025 | 78.49 USD |
| 9/18/2025 | 80.15 USD |
| 9/17/2025 | 78.87 USD |
| 9/16/2025 | 78.44 USD |
| 9/15/2025 | 79.30 USD |
| 9/12/2025 | 80.28 USD |
| 9/11/2025 | 82.01 USD |
| 9/10/2025 | 81.02 USD |
| 9/9/2025 | 84.36 USD |
| 9/8/2025 | 84.80 USD |
| 9/5/2025 | 85.65 USD |
| 9/4/2025 | 85.81 USD |
| 9/3/2025 | 83.75 USD |
| 9/2/2025 | 83.92 USD |
| 8/29/2025 | 82.90 USD |
| 8/28/2025 | 82.76 USD |
| 8/27/2025 | 84.61 USD |
| 8/26/2025 | 84.02 USD |
| 8/25/2025 | 85.47 USD |
| 8/22/2025 | 87.44 USD |
| 8/21/2025 | 84.47 USD |
| 8/20/2025 | 84.11 USD |
| 8/19/2025 | 84.75 USD |
| 8/18/2025 | 84.27 USD |
| 8/15/2025 | 85.39 USD |
| 8/14/2025 | 85.98 USD |
| 8/13/2025 | 88.52 USD |
| 8/12/2025 | 87.49 USD |
| 8/11/2025 | 86.71 USD |
US Physical Therapy Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
US Physical Therapy Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 264.00 | 305.00 | 331.00 | 356.00 | 414.00 | 453.00 | 481.00 | 422.00 | 495.00 | 553.00 | 604.00 | 671.00 | 780.00 | 838.00 | 895.00 | 980.00 |
| 4.76 | 15.53 | 8.52 | 7.55 | 16.29 | 9.42 | 6.18 | -12.27 | 17.30 | 11.72 | 9.22 | 11.09 | 16.24 | 7.44 | 6.80 | 9.50 |
| 24.24 | 24.92 | 23.56 | 23.03 | 21.74 | 22.30 | 23.28 | 22.27 | 23.64 | 20.25 | 20.03 | 18.33 | 20.13 | 20.13 | 20.13 | 20.13 |
| 64.00 | 76.00 | 78.00 | 82.00 | 90.00 | 101.00 | 112.00 | 94.00 | 117.00 | 112.00 | 121.00 | 123.00 | 157.00 | 168.67 | 180.15 | 197.26 |
| 38.00 | 45.00 | 47.00 | 49.00 | 54.00 | 60.00 | 69.00 | 53.00 | 71.00 | 56.00 | 52.00 | 63.00 | 80.00 | 95.00 | 102.00 | 112.00 |
| 14.39 | 14.75 | 14.20 | 13.76 | 13.04 | 13.25 | 14.35 | 12.56 | 14.34 | 10.13 | 8.61 | 9.39 | 10.26 | 11.34 | 11.40 | 11.43 |
| 12.00 | 19.00 | 22.00 | 20.00 | 22.00 | 10.00 | 28.00 | 30.00 | 27.00 | 28.00 | 14.00 | 26.00 | 15.00 | 42.00 | 51.00 | 54.00 |
| -29.41 | 58.33 | 15.79 | -9.09 | 10.00 | -54.55 | 180.00 | 7.14 | -10.00 | 3.70 | -50.00 | 85.71 | -42.31 | 180.00 | 21.43 | 5.88 |
| 0.40 | 0.48 | 0.60 | 0.68 | 0.80 | 0.92 | 1.14 | 1.28 | 1.46 | 1.64 | 1.72 | 1.76 | 1.80 | 1.84 | 2.02 | 2.21 |
| -47.37 | 20.00 | 25.00 | 13.33 | 17.65 | 15.00 | 23.91 | 12.28 | 14.06 | 12.33 | 4.88 | 2.33 | 2.27 | 2.22 | 9.78 | 9.41 |
| 12.12 | 12.27 | 12.42 | 12.52 | 12.59 | 12.69 | 12.77 | 12.85 | 12.91 | 13.00 | 14.99 | 15.06 | 15.18 | 15.18 | 15.18 | 15.18 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales US Physical Therapy generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue US Physical Therapy retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare US Physical Therapy's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares US Physical Therapy has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against US Physical Therapy's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
US Physical Therapy stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
US Physical Therapy Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
US Physical Therapy business model & stock analysis
US Physical Therapy Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
US Physical Therapy Segments
US Physical Therapy Revenue by Segment (1/2)
3 Years
5 Years
Max
Details
US Physical Therapy Revenue by Segment (2/2)
3 Years
5 Years
Max
Details
US Physical Therapy Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
US Physical Therapy historical P/E ratio, EBIT multiple, and P/S ratio
US Physical Therapy annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
US Physical Therapy shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
US Physical Therapy stock splits
US Physical Therapy Dividend History
16 years of dividend payments · 5 consecutive increases
US Physical Therapy dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
US Physical Therapy dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current US Physical Therapy forecasts and price targets in August 2026
Analyst Price Targets 2026US Physical Therapy Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 6/24/2026 | Maintained | Market Outperform | – | |
| 5/13/2026 | Maintained | Outperform | – | |
| 5/8/2026 | Maintained | Market Outperform | – | |
| 2/20/2026 | Maintained | Outperform | – | |
| 1/5/2026 | Maintained | Outperform | – | |
| 11/24/2025 | Maintained | Overweight | 80 | |
| 10/24/2025 | Maintained | Outperform | – | |
| 8/8/2025 | Maintained | Outperform | – | |
| 7/1/2025 | Maintained | Outperform | – | |
| 4/22/2025 | Maintained | Market Outperform | – |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
US Physical Therapy Earnings Calls
US Physical Therapy Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/4/2026 | 0.86USD | - | 215.53 MUSD | - | 2026 Q2 |
| 5/5/2026 | 0.56USD | - | 205.03 MUSD | - | 2026 Q1 |
| 3/4/2026 | 0.68USD | - | 204.43 MUSD | - | 2025 Q4 |
| 11/7/2024 | 0.69USD | - | 167.79 MUSD | - | 2024 Q3 |
| 5/1/2024 | 0.67USD | - | 156.97 MUSD | - | 2024 Q1 |
| 2/20/2024 | 0.58USD | - | 153.43 MUSD | - | 2023 Q4 |
| 8/2/2023 | 0.88USD | - | 149.65 MUSD | - | 2023 Q2 |
| 5/3/2023 | 0.65USD | - | 142.35 MUSD | - | 2023 Q1 |
| 2/22/2023 | 0.57USD | - | 143.72 MUSD | - | 2022 Q4 |
| 11/2/2022 | 0.57USD | - | 140.30 MUSD | - | 2022 Q3 |
EESG©
Eulerpool ESG Scorecard© for the US Physical Therapy stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
US Physical Therapy shareholder structure
| % | Name |
|---|---|
14.52968% | |
7.01221% | |
6.59518% | |
5.56176% | |
5.50547% | |
4.36883% |
US Physical Therapy Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
82.70% | SEC ↗ | |
15.90% | SEC ↗ | |
14.20% | SEC ↗ | |
12.00% | SEC ↗ | |
12.00% | SEC ↗ | |
9.50% | SEC ↗ | |
9.36% | SEC ↗ | |
9.18% | SEC ↗ | |
8.00% | SEC ↗ | |
7.24% | SEC ↗ |
US Physical Therapy Executives and Management Board
12 members · avg. age 63 · 25 % women
Mr. Christopher Reading (61)
Chairman of the Board, Chief Executive Officer · since 2003
3.64 M USD
Management
Mr. Eric Williams (60)
President, Chief Operating Officer
Mr. Graham Reeve (61)
Chief Operating Officer - West
Mr. Carey Hendrickson (62)
Chief Financial Officer
Mr. Richard Binstein (64)
Executive Vice President, General Counsel, Secretary
Mr. Michael Mayrsohn (38)
Chief Executive Officer of Metro, Director · since 2024
Board of Directors
Dr. Bernard Harris (68)
Lead Independent Director
Mr. Clayton Trier (73)
Independent Director
Ms. Kathleen Gilmartin (73)
Independent Director
Mr. Reginald Swanson (71)
Independent Director
Ms. Nancy Ham (63)
Independent Director
Ms. Anne Motsenbocker (63)
Independent Director
US Physical Therapy Supply Chain
Frequently asked questions about US Physical Therapy
The business model of U.S. Physical Therapy Inc. revolves around providing outpatient physical therapy services through a network of clinics. With a focus on orthopedic conditions and musculoskeletal problems, the company aims to enhance patients' physical health and promote recovery. U.S. Physical Therapy operates through its clinics located nationwide, offering services such as therapeutic exercises, manual therapy, and specialized programs. By employing licensed therapists and utilizing evidence-based practices, the company strives to deliver high-quality patient care and optimize outcomes. U.S. Physical Therapy's business model centers on offering accessible and effective physical therapy solutions to individuals seeking rehabilitation services.
U.S. Physical Therapy Inc is primarily active in the healthcare industry.
The main competitors of U.S. Physical Therapy Inc in the market include companies such as Select Medical Holdings Corporation, ATI Physical Therapy, and NovaCare Rehabilitation. These companies operate in a similar industry and provide a range of physical therapy services, competing for market share and customer base. However, U.S. Physical Therapy Inc stands out with its strong reputation, comprehensive healthcare solutions, and a customer-centric approach that sets it apart from competitors.
U.S. Physical Therapy Inc. is a renowned company in the healthcare industry. Founded in 1990, it has emerged as a leading provider of outpatient physical therapy services across the United States. With a strong commitment to patient care, the company focuses on delivering high-quality rehabilitation services that enhance mobility, alleviate pain, and improve overall well-being. U.S. Physical Therapy Inc. operates a vast network of clinics, partnering with individuals, physicians, and insurance companies to provide comprehensive care. Leveraging its expertise and state-of-the-art facilities, the company continues to make strides in the field of physical therapy, ensuring patients receive personalized and effective treatment options.
U.S. Physical Therapy Inc has achieved various significant milestones throughout its history. Notably, the company has successfully expanded its network, becoming one of the largest outpatient physical therapy providers in the United States. Additionally, it has consistently delivered strong financial performance, demonstrating steady revenue growth and profitability. Through strategic acquisitions and partnerships, U.S. Physical Therapy Inc has enhanced its market presence and diversified its service offerings. The company remains focused on delivering high-quality patient care and continues to leverage its expertise to drive innovation in the physical therapy industry.
U.S. Physical Therapy Inc primarily operates in the United States.
U.S. Physical Therapy Inc represents a commitment to providing high-quality rehabilitation services. The company values patient care and aims to help individuals regain physical well-being. With a focus on evidence-based treatment, U.S. Physical Therapy Inc ensures the use of advanced technology and clinical expertise. The company's corporate philosophy centers around delivering personalized care tailored to each patient's unique needs. U.S. Physical Therapy Inc strives to foster a supportive and compassionate environment, promoting wellness and improved quality of life. By continuously prioritizing patient satisfaction and employing skilled professionals, the company consistently upholds its commitment to delivering exceptional rehabilitation services.
Analysts currently set an average price target of 104.04 USD for the US Physical Therapy stock (median: 103.53 USD), implying +30.0 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the US Physical Therapy stock: 11 recommend buying, 2 holding and 0 selling. For 2026, analysts expect US Physical Therapy to generate revenue of 838.68 M USD and earnings per share of 2.80 USD.
Converted at the current exchange rate, the US Physical Therapy share trades at 66.21 EUR (76.46 USD).
The US Physical Therapy share (USPH) is listed on 2 stock exchanges, including: NYSE (USPH), Frankfurt (UPH.F).
U.S. Physical Therapy Inc is a leading company in the field of physical therapy. The company offers a variety of products and services that allow customers to improve their physical health and well-being. The company operates in three main business areas. The first area is outpatient rehabilitation, the second area is management services for clinical partners, and the third area is IT and software solutions for healthcare facilities. In the field of outpatient rehabilitation, U.S. Physical Therapy Inc operates a variety of physical therapy centers that offer a wide range of services including physical therapy, pain management, neurorehabilitation, occupational therapy, speech therapy, and more. The company's extensive experience in this field allows it to offer high-quality treatments and provide patients with personalized care and rehabilitation. In the area of management services for clinical partners, U.S. Physical Therapy Inc helps clinics and facilities optimize their business operations. This includes services such as taking on management tasks, providing staffing resources, and implementing technology solutions. The company has extensive experience in managing therapy practices and medical facilities to ensure their long-term success. In the IT and software solutions for healthcare facilities sector, U.S. Physical Therapy Inc offers a range of innovative products and services for healthcare providers. This includes cloud-based software solutions for patient management, payment billing, appointment scheduling, medical records, and more. These solutions help facilities improve operational efficiency and provide better patient care. In addition to the above-mentioned business areas, U.S. Physical Therapy Inc also offers specialized products and services including work and sports injuries, hand therapy, vestibular therapy, wound care, and more. The company has extensive experience in treating patients with a variety of health conditions and provides comprehensive resources for diagnosis and treatment of diseases. Overall, U.S. Physical Therapy Inc's business model is focused on helping people improve their physical health and well-being. The company offers a wide range of products and services, from physical therapy to management solutions for clinical partners and software solutions for healthcare providers. Thanks to its experience and commitment, U.S. Physical Therapy Inc is now a leading company in the field of physical therapy.
The expected revenue of US Physical Therapy is 838.68 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of US Physical Therapy is 42.52 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of US Physical Therapy is currently 27.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the US Physical Therapy stock.
The price-to-sales ratio (P/S) of US Physical Therapy is currently 1.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the US Physical Therapy stock.
The Eulerpool Quality Score for US Physical Therapy is 8/10.
The ISIN of US Physical Therapy is US90337L1089. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of US Physical Therapy is 923954. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of US Physical Therapy is USPH. The ticker symbol is used to trade US Physical Therapy shares on the stock exchange.
Over the past 12 months, US Physical Therapy paid a dividend of 1.80 USD . This corresponds to a dividend yield of about 2.35 %. For the coming 12 months, US Physical Therapy is expected to pay a dividend of 2.02 USD.
The current dividend yield of US Physical Therapy is 2.35 %.
US Physical Therapy pays a dividend, distributed in the months of , , , .
US Physical Therapy paid dividends every year for the past 15 years.
For the upcoming 12 months, dividends amounting to 2.02 USD are expected. This corresponds to a dividend yield of 2.64 %.
US Physical Therapy is assigned to the 'Health' sector.
In the year 2025, US Physical Therapy distributed 1.76 USD as dividends.
The dividends of US Physical Therapy are distributed in USD.
US Physical Therapy stock
US Physical Therapy Peer Group
US Physical Therapy Ticker
US Physical Therapy FIGI
All fundamentals and in-depth analysis of US Physical Therapy
Our stock analysis for US Physical Therapy stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of US Physical Therapy. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.